3D excretory MR urography: Improved image quality with intravenous saline and diuretic administration

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 4, 2007, Pages 783-789

  Ergen, F Bilge ^a,b   Hussain, Hero K ^a   Carlos, Ruth C ^a   Johnson, Timothy D ^a   Adusumilli, Saroja ^a   Weadock, William J ^a   Korobkin, Melvyn ^a   Francis, Isaac R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Diuretics; Gd DTPA; MR urography; Urinary

Indexed keywords

DIURETIC AGENT; FUROSEMIDE; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; ARTIFACT REDUCTION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ECHO PLANAR IMAGING; FEMALE; HUMAN; HYDRATION; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; INTRAVENOUS UROGRAPHY; KIDNEY CALYX; KIDNEY PELVIS; MAGNETIC RESONANCE UROGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; THREE DIMENSIONAL ECHOCARDIOGRAPHY; URETER;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIURETICS; FUROSEMIDE; GADOLINIUM; HUMANS; IMAGING, THREE-DIMENSIONAL; INJECTIONS, INTRAVENOUS; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OBSERVER VARIATION; SODIUM CHLORIDE; URINARY TRACT; UROGRAPHY;

EID: 34047144427     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20875     Document Type: Article

References (32)

1. Rothpearl A, Frager D, Subramanian A, et al. MR urography: technique and application. Radiology 1995;194:125-130.
2. Hussain S, O'Malley M, Jara H, Sadeghi-Nejad H, Yucel EK. MR urography. Magn Reson Imaging Clin N Am 1997;5:95-106.
3. Regan F, Bohlman ME, Khazan R, Rodriguez R, Schultze-Haakh H. MR urography using HASTE imaging in the assessment of ureteric obstruction. AJR Am J Roentgenol 1996;167:1115-1120.
4. Sigmund G, Stoever B, Zimmerhackl LB, et al. RARE-MR-urography in the diagnosis of upper urinary tract abnormalities in children. Pediatr Radiol 1991;21:416-420.
5. Louca G, Liberopoulos K, Fidas A, et al. MR urography in the diagnosis of urinary tract obstruction. Eur Urol 1999;35:102-108.
6. Tang Y, Yamashita Y, Namimoto T, et al. The value of MR urography that uses HASTE sequences to reveal urinary tract disorders. AJR Am J Roentgenol 1996;167:1497-1502.
7. Roy C, Saussine C, Guth S, et al. MR urography in the evaluation of urinary tract obstruction. Abdom Imaging 1998;23:27-34.
8. Roy C, Saussine C, Jahn C, et al. Evaluation of RARE-MR urography in the assessment of ureterohydronephrosis. J Comput Assist Tomogr 1994;18:601-608.
9. Nolte-Ernsting C, Adam G, Bucker A, Berges S, Bjornerud A, Gunther RW. Contrast enhanced magnetic resonance urography. First experimental results with a polymeric gadolinium blood pool agent. Invest Radiol 1997;32:418-423.
10. Nolte-Ernsting CC, Bucker A, Adam GB, et al. Gadolinium-enhanced excretory MR urography after low-dose diuretic injection: comparison with conventional excretory urography. Radiology. 1998;209:147-157.
11. Nolte-Ernsting CC, Tacke J, Adam GB, et al. Diuretic-enhanced gadolinium excretory MR urography. comparison of conventional gradient-echo sequences and echo-planar imaging. Eur Radiol 2001;11:18-27.
12. Verswijvel GA, Oyen RH, Van Poppel HP. Magnetic resonance imaging in the assessment of urologic disease: an all-in-one approach. Eur Radiol 2000;10:1614-1619.
13. Nolte-Ernsting CC, Adam GB, Gunther RW. MR urography: examination techniques and clinical applications. Eur Radiol 2001;11:355-372.
14. Farres MT, Gattegno B, Ronco P, Flahault A, Paula-Souza R, Bigot JM. Nonnephrotoxic, dynamic, contrast enhanced magnetic resonance urography: use in nephrology and urology. J Urol 2000;163:1191-1196.
15. Li W, Chavez D, Edelman RR, Prasad PV. Magnetic resonance urography by breathhold contrast-enhanced three-dimensional FISP. J Magn Reson Imaging 1997;7:309-311.
16. Alagappan R, Hricak H. The kidneys. In: Higgins CB, Hricak H, Helms CA, editors. Magnetic resonance imaging of the body, 3rd edition. Philadelphia: Lippincot-Raven; 1997. p 728.
17. Good P. Testing Hypothesis. In: Good P, editor. Permutation tests, 2nd edition. New York: Springer-Verlag, Inc; 2000. p 31-42.
18. Prince MR, Grist TM, Debatin JF. Basic Concepts. In: Prince MR, Grist TM, Debatin JF, editors. 3D contrast MR angiography, 2nd edition. Berlin: Springer-Verlag; 1998. p 27-28.
19. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996;6:162-166.
20. Weissleder R. Can gadolinium be safely given in renal failure? AJR Am J Roentgenol 1996;167:278-279.
21. Ergun I, Keven K, Uruc I, et al. The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 2006;21:697-700.
22. Hoffmann U, Fischereder M, Reil A, Fischer M, Link J, Kramer BK. Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function. Eur J Med Res 2005;10:149-154.
23. Helmberger T, Semelka RC. New contrast agents for imaging the liver. Magn Reson Imaging Clin N Am 2001;9:745-766.
24. Low RN. MR imaging of the liver using gadolinium chelates. Magn Reson Imaging Clin N Am 2001;9:717-743.
25. Kuperman VY, Karczmar GS, Blomley MJ, Lewis MZ, Lubich LM, Lipton MJ. Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence. J Magn Reson Imaging 1996;6:764-768.
26. Krestin GP. Genitourinary MR: kidneys and adrenal glands. Eur Radiol 1999;9:1705-1714.
27. Mitchell, DB. Artifacts. In: Mitchell DB, editor. MRI principles. Philadelphia: W.B. Saunders; 1999. p 267.
28. Warnock DG. Diuretic agents. In: Katzung BG, editor. Basic and clinical pharmacology. Los Angeles: Appleton & Lange; 1996. p 217-219.
29. Jackson EK. Diuretics. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman & Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill; 1996. p 691-692.
30. Szopinski K, Szopinska M, Borowka A, Jakubowski W. Magnetic resonance urography: initial experience of a low-dose Gd-DTPA-enhanced technique. Eur Radiol 2000;10:1158-1164.
31. Hughes J, Jan W, Goodie J, Lund R, Rankin S. MR urography: evaluation of different techniques in non-dilated tracts. Clin Radiol 2002;57:989-994.
32. Hansbrough JR, Wedner HJ, Chaplin DD. Anaphylaxis to intravenous furosemide. J Allergy Clin Immunol 1987;80:538-541.